BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou J, Chng WJ. Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma. World J Clin Oncol 2019; 10(9): 303-306 [PMID: 31572666 DOI: 10.5306/wjco.v10.i9.303]
URL: https://www.wjgnet.com/2218-4333/full/v10/i9/303.htm
Number Citing Articles
1
Yang Bai, Xing Su. Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myelomaAsia-Pacific Journal of Clinical Oncology 2021; 17(1): 29 doi: 10.1111/ajco.13459
2
Dong Wu, Jiyu Miao, Jinsong Hu, Fangmei Li, Dandan Gao, Hongli Chen, Yuandong Feng, Ying Shen, Aili He. PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to BortezomibFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.684232
3
Guoyuan Tang, Shan Huang, Ji Luo, Yingmiao Wu, Shuai Zheng, Rongsheng Tong, Ling Zhong, Jianyou Shi. Advances in research on potential inhibitors of multiple myelomaEuropean Journal of Medicinal Chemistry 2023; 262: 115875 doi: 10.1016/j.ejmech.2023.115875
4
Satyendra Chandra Tripathi, Disha Vedpathak, Edwin Justin Ostrin. The Functional and Mechanistic Roles of Immunoproteasome Subunits in CancerCells 2021; 10(12): 3587 doi: 10.3390/cells10123587
5
Sinan Xiong, Wee-Joo Chng, Jianbiao Zhou. Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myelomaCellular and Molecular Life Sciences 2021; 78(8): 3883 doi: 10.1007/s00018-021-03756-3
6
Ana Savia Cardoso Brito, Gildeanni Iasmim Alves Vieira, Alessandra Souza dos Santos, Aroldo Mazur Barbosa da Silva. PROBIÓTICOS NO TRATAMENTO DO MIELOMA MÚLTIPLO: UMA REVISÃORECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 2024; 5(6): e565340 doi: 10.47820/recima21.v5i6.5340
7
Miao Yuan, Hanwen Ji, Fengxin Sun, Qiang Chen, Ping Cheng. Rational design of novel phenol ether derivatives as non-covalent proteasome inhibitors through 3D-QSAR, molecular docking and ADMET predictionExploration of Drug Science 2023; : 435 doi: 10.37349/eds.2023.00029
8
Joelle C. Boulos, Mohamed E. M. Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo, Doris Marko, Markus Munder, Sabine M. Klauck, Thomas Efferth. Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma CellsPharmaceuticals 2021; 14(11): 1126 doi: 10.3390/ph14111126
9
Noa Biran,, Pooja Phull,, Andre Goy. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies2023; : 331 doi: 10.1002/9781119819950.ch24